Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 26, 2021; 9(3): 758-763
Published online Jan 26, 2021. doi: 10.12998/wjcc.v9.i3.758
Published online Jan 26, 2021. doi: 10.12998/wjcc.v9.i3.758
Restenosis of a drug eluting stent on the previous bioresorbable vascular scaffold successfully treated with a drug-coated balloon: A case report
Hyun Gyung Jang, Kyehwan Kim, Hyun Woong Park, Jin-Sin Koh, Jeong Rang Park, Min Gyu Kang, Department of Internal Medicine, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, South Korea
Young-Hoon Jeong, Department of Internal Medicine, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, South Korea
Author contributions: Kang MG were the patient’s interventional cardiologist, reviewed the literature and contributed to manuscript drafting; Jang HG reviewed the literature and contributed to manuscript drafting; Kim K and Park HW performed the interpretation of coronary imaging modality and contributed to manuscript drafting; Koh JS and Park JR analyzed and interpreted the imaging findings; Jeong YH performed the pharmacologic strategy for coronary artery diseases consultation, reviewed the literature and drafted the manuscript; Kang MG and Jang HG were responsible for the revision of the manuscript for important intellectual content; all authors issued final approval for the version to be submitted.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Min Gyu Kang, MD, PhD, Department of Internal Medicine, Gyeongsang National University of Medicine and Gyeongsang National University Hospital, 79 Gangnam-ro, Jinju 52727, South Korea. med2floyd@naver.com
Received: November 27, 2020
Peer-review started: November 27, 2020
First decision: December 21, 2020
Revised: December 22, 2020
Accepted: December 30, 2020
Article in press: December 30, 2020
Published online: January 26, 2021
Processing time: 54 Days and 5.4 Hours
Peer-review started: November 27, 2020
First decision: December 21, 2020
Revised: December 22, 2020
Accepted: December 30, 2020
Article in press: December 30, 2020
Published online: January 26, 2021
Processing time: 54 Days and 5.4 Hours
Core Tip
Core Tip: In-stent restenosis still poses a limitation of percutaneous coronary intervention and bioresorbable vascular scaffold are associated with a high rate of target lesion revascularization We present herein, a rare case of restenosis of a drug eluting stent on the previous bioresorbable vascular scaffold. Optical coherence tomography is an instrumental imaging modality for identifying the mechanisms underlying target lesion failure. Drug-coated balloon following the administration of optimal pharmacologic therapy may be an optimal strategy for the treatment and prevention of recurrent target lesion failure.